Avi Raval

Avi Raval is a Managing Director at PJT Partners, focusing on healthcare strategic advisory. His expertise is uniquely shaped by his past experience as the CFO and CBO of Synthego, a genome engineering company, and his education from The Wharton School and the University of Pennsylvania.

He demonstrates a strong interest in the real-world impact of healthcare innovation. Avi is a vocal supporter of policies aimed at improving patient access to advanced treatments like cell and gene therapies, showing a commitment that extends beyond pure financial advisory.

Unique fact: He has operational experience as a C-suite executive at a biotech company, a rare background for a career investment banker.